-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Initiates Coverage On Tiziana Life Sciences with Buy Rating, Announces Price Target of $7

Benzinga·09/03/2026 10:08:14
語音播報
BTIG analyst Thomas Shrader initiates coverage on Tiziana Life Sciences (NASDAQ:TLSA) with a Buy rating and announces Price Target of $7.